Ibrutinib/ibrutinib Bangladesh version

Ibrutinib/Ibrutinib is a drug called a kinase inhibitor that is used to treat various blood cancers and a serious complication of allogeneic stem cell transplants called chronic graft-versus-host disease (cGVHD). The original ibrutinib drug is currently on the market for sale in many countries at home and abroad. There is also a Bangladeshi version of ibrutinib generic drug produced and sold. Its pharmaceutical ingredients are basically the same as those of the original drug sold domestically and abroad. There may be some differences in production specifications and prices. Common manufacturers include Bangladesh Yaopin International, Everest Pharmaceuticals, Beacon Pharmaceuticals, etc.

Ibrutinib helps slow the growth of certain blood cancers by fighting cancer-causing B cells (a type of white blood cell)B cells. It does this by blocking Bruton's tyrosine kinase (BTK) signaling. BTK is a protein found on B cells that instructs them to stay alive and reproduce. , thus playing a role in the treatment of mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and Waldenstrom's macroglobulinemia (WM). Ibrutinib also blocks the activity of a similar protein called interleukin-2-inducible T-cell kinase (ITK). It is thought that this action and its ability to block BTK could help treat chronic graft-versus-host disease. It is not known whether ibrutinib is safe and effective in children younger than 1 year old.

Common specifications of ibrutinib generics sold overseas140mg*120 capsules, each box may cost only a few hundred to 1,000 yuan (the specific price may fluctuate due to exchange rate changes).